AUTHORS
Rohini Muthukumar, PhD, Helen C. Wang, PhD2, Riddhi Patel3, Emily B. Casey4, Jeffrey Magee, MD, PhD5
AFFILIATIONS
1 Washington University School of Medicine, St Louis, Missouri, United States
2 Washington University School of Medicine, St Louis, Missouri, United States
3 Washington University School of Medicine, St Louis, Missouri, United States
4 Washington University School of Medicine, St Louis, Missouri, United States
5 Washington University School of Medicine, St Louis, Missouri, United States
ABSTRACT
MLL3 and MLL4 are epigenetic regulators that act redundantly to maintain hematopoietic stem cell (HSC) and multipotent progenitor (MPP) multipotency. In the absence of these proteins, essentially all immature progenitors default to a B-cell like state, and myeloid, erythroid and megakaryocytic potential is lost. These changes are accompanied by inactivation of superenhancers that maintain HSC/MPP identity, including superenhancers that map near Gata2, Mecomand Runx1. It is not clear how MLL3/4 regulates these enhancers. We previously showed that the SET domain in each protein, which places histone H3, lysine 4 mono methylation (H3K4me1) marks at enhancers, is dispensable for MLL3/4 function.
MLL3 and MLL4 nucleate a large multiprotein complex called the COMPASS, suggesting that COMPASS might functions as a cohesive unit to control HSC/MPP fate. Indeed, prior studies have suggested that a primary function of MLL3/4 is to bind chromatin or chromatin-associated proteins via N-terminal PHD domains and recruit COMPASS family members to the region. MLL3/4 COMPASS contains several proteins that have known roles in hematopoiesis. WDR5, RBBP5, ASH2L and DPY30, interface with the SET domain and modulate histone tail recognition and methylation. Other MLL3/4 COMPASS proteins include UTX, PTIP and NCOA6. Interestingly, Utx and Ptip loss-of-function phenotypes do not resemble Mll3/4 loss-of-function, indicating that they are dispensable to the primary activities of Mll3/4 in HSCs. This challenges the notion that MLL3, MLL4 and other COMPASS subunits function as a cohesive unit to regulate HSC fate. However, Ncoa6 has not been studied for a role in hematopoiesis, raising the question of whether Ncoa6 deficiency would recapitulate some, or all, key functions of the MLL3/4 COMPASS.
To test whether Ncoa6 regulates HSC self-renewal and differentiation, and whether it mediates MLL3/4 function, we conditionally deleted Ncoa6 in hematopoietic progenitors. Ncoa6 deletion modestly increased HSC numbers and reduced MPP2 and MPP3/4 numbers. pGM (pre-granulocyte-macrophage progenitors) and GMP (granulocyte-monocyte progenitor) numbers unaffected. These population shifts resemble effects of deleting Mll3 alone, but not Mll4 alone or Mll3/4 together. However, in contrast to Mll3 deletion, which enhances HSC self-renewal, Ncoa6 deletion impaired HSC self-renewal in serial transplantation assays. The self-renewal defect was most evident in secondary transplants. Similarly, whereas Mll3/4 deletion causes hematopoietic progenitors to activate B-cell programs and lose myeloerythroid potential, multilineage differentiation was preserved following Ncoa6 deletion. Together, these data show that Ncoa6 is dispensable for steady-state hematopoiesis, though it helps maintain long-term HSC self-renewal.
Our data challenge the premise that the primary function of MLL3 and MLL4 in HSCs occurs via the canonical COMPASS. In fact, inactivating MLL3/4-specific COMPASS members, including UTX, PTIP and now NCOA6, does not recapitulate either the individual or redundant changes in gene expression or function that ensue in HSCs after Mll3/4deletion. MLL3/4 therefore regulate HSC/MPP superenhancers independently of COMPASS co-factors.
DISCLOSURES
Rohini Muthukumar, PhD: No relevant conflicts of interest to declare.